Genexine Refinances KRW 41.44 Billion in Project Debt With Secured Loan

• Genexine will record KRW 41.44 billion in short-term borrowings from refinancing project-finance loans for its Magok headquarters and R&D center.
• New secured loans from financial institutions will replace existing debt without additional borrowing.
• Magok Consortium First is the borrower; the amount reflects Genexine’s ownership share in the consortium.
• The loans run for 12 months from the initial drawdown on November 6, 2026.
• The board authorized the refinancing on November 2, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genexine Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261102900890), on November 02, 2026, and is solely responsible for the information contained therein.